Chongqing Xishan Science & Technology Co., Ltd. (SHA:688576)

China · Delayed Price · Currency is CNY

36.63

-1.15 (-3.04%)

Oct 27, 2026, 4:00 PM EDT

SHA:688576 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	306.53	341.99	336.38	360.69	262.27	208.86
Revenue Growth	-9.85%	1.67%	-6.74%	37.52%	25.57%	63.97%
Gross Profit	172.95	210.22	233.43	247.34	179.02	145.47
Operating Income	-33.81	26	65.33	90.38	62.7	49.75
Net Income	-7.94	51.91	98.67	117.34	75.35	61.43
Earnings Per Share	-0.12	0.77	1.32	1.70	1.28	1.12
EPS Growth	-	-41.62%	-22.14%	33.16%	13.92%	265.34%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Medical Instruments	337.02
Other	4.05
Total	341.06

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,152	725.1	993.02	1,586	332.89	304.24
Total Debt	-	-	0.13	3.09	6.17	9.43
Net Cash (Debt)	1,152	725.1	992.89	1,583	326.72	294.8
Net Cash Growth	33.72%	-26.97%	-37.29%	384.60%	10.82%	194.20%
Net Cash Per Share	17.18	10.78	13.30	22.91	5.53	5.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-9.53	60.03	39.47	68.08	79.1	55.88
Capital Expenditures	-64.31	-96	-157.55	-103.72	-49.15	-14.18
Free Cash Flow	-73.84	-35.96	-118.08	-35.64	29.95	41.7
Free Cash Flow Growth	-	-	-	-	-28.17%	26.18%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	56.42%	61.47%	69.39%	68.57%	68.26%	69.65%
Operating Margin	-11.03%	7.60%	19.42%	25.06%	23.91%	23.82%
Pretax Margin	-3.04%	15.52%	33.11%	35.23%	28.48%	29.13%
Profit Margin	-2.59%	15.18%	29.33%	32.53%	28.73%	29.41%
FCF Margin	-24.09%	-10.51%	-35.10%	-9.88%	11.42%	19.96%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	0.336	0.336	0.671	0.671
Dividend Per Share Growth	-25.50%	-49.99%	0%	-
Dividend Yield	0.92%	0.79%	1.71%	1.04%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	54.81	27.30	43.42	-	-
Forward PE	-	17.59	18.32	33.49	-	-
PS Ratio	8.03	8.32	8.01	14.13	-	-